Physician profile
Damon T Jenkins
NPI 1891890463
$9,438.55
in general payments reported to CMS, 2019-2025
11 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.30 · 2020: $79.19 · 2021: $2,201 · 2022: $6,821 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $200 · Food and Beverage: $48.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $200.00 |
| Food and Beverage | $48.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Planmeca USA, INC. | $8,504.89 | 2019-2022 | |
| Straumann USA LLC | $396.86 | 2020-2025 | |
| Thommen Medical USA, LLC | $293.21 | 2022 | |
| Zimvie INC. | $56.50 | 2022 | |
| Patterson Companies, INC. | $48.66 | 2025 | |
| Dentsply Sirona INC | $44.21 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $27.50 | 2021 | |
| 3m Company | $23.11 | 2021 | |
| Nobel Biocare USA | $15.95 | 2019 | |
| Henry Schein, INC. | $15.04 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $12.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damon Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.